Musk’s drug use concerns Tesla, SpaceX leaders, report says

Elon Musk’s drug use has worried executives and board members at businesses he runs, the Wall Street Journal reported, citing unidentified people familiar with the billionaire and the companies. Musk has used LSD, cocaine, ecstasy, and psychedelic mushrooms, often at private parties, the Journal said, citing unnamed witnesses and others with knowledge of the matter. People close to the Tesla Inc. and SpaceX chief executive told the newspaper his drug use is ongoing, and that in particular he’s consuming ketamine.

Musk said in August he has a prescription to use the drug as an antidepressant. Musk, 52, didn’t respond to the Journal’s requests for comment. Alex Spiro, an attorney for the billionaire, told the newspaper that his client is “regularly and randomly drug tested at SpaceX and has never failed a test,” and referred to “false facts” in the article but didn’t detail them. Musk’s public use of marijuana with podcaster Joe Rogan in September 2018 led the Pentagon to review the federal security clearance tied to his role as CEO of Space Exploration Technologies Corp., which is certified to launch military spy satellites, Bloomberg News first reported in March 2019. Musk responded to the WSJ article on X Sunday: “After that one puff with Rogan, I agreed, at NASA’s request, to do 3 years of random drug testing. Not even trace quantities were found of any drugs or alcohol.” Musk oversees six companies: Tesla, SpaceX, and X, the social media company formerly known as Twitter; the tunneling venture The Boring Co.; brain implant developer Neuralink; and artificial intelligence startup xAI. His $219.4 billion net worth ranks No. 1 on the Bloomberg Billionaires Index.